IndiaGermany businesses drive earnings

Company
24 Jul 2024
5 Min read 
  • Torrent Pharma's 1QFY25 results update and financials.
  •  Sales growth in different segments and geographical regions.
  •  Management commentary and key takeaways from the interaction.
  •  Valuation and earnings estimates for FY25 and FY26.
  •  Financial ratios and cash flow statement analysis.
  •  Growth levers across segments and future prospects.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority